DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma.

Annals of Hematology
Scott R GoldsmithRavi Vij

Abstract

Multiple myeloma (MM) almost invariably progresses through novel therapies. Patients with quad-refractory MM (refractory to bortezomib, carfilzomib, lenalidomide, and pomalidomide) and penta-refractory MM (additional refractoriness to daratumumab) have few treatment options. Two chemotherapy regimens, bendamustine/prednisone (BP) and dexamethasone, cyclophosphamide, etoposide, and cisplatin (DCEP), are often used in quad- and penta-refractory MM, but there are limited data on outcomes in this heavily pre-treated population. We conducted a single-center retrospective study to identify all patients who received DCEP and/or BP for quad- or penta-refractory MM. Disease response and refractoriness were defined by International Myeloma Working Group criteria. The primary endpoint was overall response rate (ORR). Secondary endpoints included overall survival (OS), progression-free survival (PFS), and duration of response (DOR). We identified 27 patients who received BP for quad- or penta-refractory MM. The median number of prior lines of therapy was 6. The ORR for BP was 26%. The median PFS for BP was 1.4 months (95% CI 1.1-1.6) and median OS was 8.7 months (95% CI 2.3-15.0). Patients treated with cyclophosphamide had less response to...Continue Reading

References

Feb 1, 1997·Hematology/oncology Clinics of North America·M Attal, J L Harousseau
Dec 10, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Varsha Gandhi, Jan A Burger
Feb 18, 2010·European Journal of Medical Research·M MichaelRoland Fenk
Feb 5, 2011·Blood·S Vincent RajkumarUNKNOWN International Myeloma Workshop Consensus Panel 1
Oct 7, 2011·Journal of the National Comprehensive Cancer Network : JNCCN·Kenneth C AndersonUNKNOWN National Comprehensive Cancer Network
Apr 14, 2012·Blood·Jonathan J KeatsP Leif Bergsagel
Nov 19, 2013·Annals of Hematology·Silvia ParkKihyun Kim
Dec 9, 2014·The New England Journal of Medicine·A Keith StewartUNKNOWN ASPIRE Investigators
Feb 20, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Ali McBrideKeith Stockerl-Goldstein
Apr 4, 2015·Blood·Philippe MoreauThierry Facon
Jun 19, 2015·European Journal of Haematology·Massimo GentileFortunato Morabito
Jul 15, 2015·Journal of Cancer Research and Clinical Oncology·Elisabeth StöhrUNKNOWN German Refractory Myeloma Study Group
Aug 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian A WalkerGareth J Morgan
Aug 27, 2015·The New England Journal of Medicine·Henk M LokhorstPaul G Richardson
Feb 18, 2016·Current Hematologic Malignancy Reports·Melissa Gaik-Ming OoiWee Joo Chng
Apr 2, 2016·Haematologica·Pieter Sonneveld, Annemiek Broijl
Aug 25, 2016·The New England Journal of Medicine·Antonio PalumboUNKNOWN CASTOR Investigators
Oct 6, 2016·The New England Journal of Medicine·Meletios A DimopoulosUNKNOWN POLLUX Investigators
Sep 13, 2017·European Journal of Haematology·Nina ShahMuzaffar Qazilbash
Jan 4, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Shaji K KumarDorothy A Shead
Jan 31, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dan T VoglA Keith Stewart
Apr 5, 2018·Leukemia & Lymphoma·Hiu Lam Agnes YuenAndrew Spencer
May 23, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·Shaji K Kumar
Nov 19, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·R Frank Cornell, Luciano J Costa
May 3, 2019·The New England Journal of Medicine·Noopur RajeJames N Kochenderfer

❮ Previous
Next ❯

Citations

Mar 13, 2021·Future Oncology·Joshua RichterMeletios Dimopoulos
Jul 25, 2021·Journal of Hematology & Oncology·Christopher T Su, J Christine Ye

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.